Articles
Page 1 of 8
-
Citation: BMC Rheumatology 2024 8:30
-
Belonging, happiness, freedom and empowerment—a qualitative study of patients’ understanding of health in early rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory joint disease, that influences patients’ health in different ways, including physical, social, emotional, and psychological aspects. The goal of r...
Citation: BMC Rheumatology 2024 8:29 -
Protocol for the development of a tool to map systemic sclerosis pain sources, patterns, and management experiences: a Scleroderma Patient-centered Intervention Network patient-researcher partnership
Systemic sclerosis (SSc) is a rare, complex autoimmune rheumatic disease with multiple factors that contribute to pain. People with SSc emphasize the effect pain has on their quality of life, but no studies ha...
Citation: BMC Rheumatology 2024 8:28 -
Nintedanib combined with immunosuppressive agents improves forced vital capacity in connective tissue disease-associated PF-ILD: a single-center study
In 2020, Nintedanib (NTB), a tyrosine kinase inhibitor, was the first drug approved worldwide for treating progressive fibrosing interstitial lung disease (PF-ILD). This study evaluated the efficacy and safety...
Citation: BMC Rheumatology 2024 8:27 -
Associations of C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio with disease activity in patients with juvenile idiopathic arthritis
Recent works in the scientific literature reported the role of C reactive protein to albumin ratio (CAR), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) as biomarkers of disease ac...
Citation: BMC Rheumatology 2024 8:26 -
Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
Vaccines are a crucial component of the global efforts to control the spread of COVID-19. Very little is known about COVID-19 vaccine responses in patients living with autoimmune rheumatic conditions in Africa...
Citation: BMC Rheumatology 2024 8:25 -
Adaptation of the comprehensive rheumatologic assessment of frailty (CRAF) as a multidimensional frailty screening tool in patients with rheumatoid arthritis in Vietnam
In recent times, there has been acknowledgment of the prevalence of frailty and pre-frailty among individuals with rheumatoid arthritis (RA). Comprehensive Rheumatologic Assessment of Frailty (CRAF) stands out...
Citation: BMC Rheumatology 2024 8:24 -
Factors affecting the duration of initial medical care seeking among older rural patients diagnosed with rheumatoid arthritis: a retrospective cohort study
Early diagnosis and treatment of rheumatoid arthritis (RA) are essential to prevent progressive joint destruction and improve the quality of life (QOL) of patients. This study aimed to identify the factors ass...
Citation: BMC Rheumatology 2024 8:23 -
Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activity
Limited real-world data exists on clinical outcomes in systemic lupus erythematosus (SLE) patients by SLE Disease Activity Index 2000 (SLEDAI-2 K), hereafter, SLEDAI. We aimed to examine the association betwee...
Citation: BMC Rheumatology 2024 8:22 -
Epidemiology and diagnosis of gout in sub-saharan Africa: a scoping review
The episodic nature of gout and diagnostic uncertainty in the absence of microcrystal evidence make it particularly difficult to estimate the frequency of gout. Our aim was to review the literature on the epid...
Citation: BMC Rheumatology 2024 8:21 -
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study
Tumor necrosis factor inhibitors (TNFi) are frequently chosen as the first biologic for patients with psoriatic arthritis (PsA). Given that many patients with PsA are TNFi inadequate responders (TNF-IR; either...
Citation: BMC Rheumatology 2024 8:20 -
Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis
Patients with rheumatoid arthritis (RA) are at risk of developing interstitial lung disease (ILD), which is associated with high mortality. Screening tools based on risk factors are needed to decide which pati...
Citation: BMC Rheumatology 2024 8:19 -
Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany
Systemic lupus erythematosus (SLE), a chronic multisystem autoimmune disease, carries high risk of organ damage and burden to healthcare systems. SLE disease modification aims to reduce disease activity with m...
Citation: BMC Rheumatology 2024 8:18 -
Association between systemic lupus erythematosus and osteoporosis: a mendelian randomization analysis
Systemic Lupus Erythematosus (SLE) and Osteoporosis are two prevalent medical conditions. Previous studies have suggested a possible correlation between SLE and osteoporosis, though the underpinning causal rel...
Citation: BMC Rheumatology 2024 8:17 -
Evolution of therapeutic management of patients with ANCA associated vasculitis in France after licensing Rituximab use
In 2013, rituximab was approved in France for the treatment of ANCA-associated vasculitis (AAV). The aim of the study was to compare the treatment and health events of adult incident patients with granulomatos...
Citation: BMC Rheumatology 2024 8:16 -
Seronegative primary Sjögren’s syndrome, a distinct subtype of primary Sjögren’s syndrome in Chinese patients
To investigate the clinical and immune characteristics of patients with primary Sjögren’s syndrome (pSS) who were negative for anti–Sjögren’s-syndrome-related antigen A antibodies (anti-SSA) and anti–Sjögren’s...
Citation: BMC Rheumatology 2024 8:15 -
Determination of IL-23 receptor expression and gene polymorphism (rs1884444) in Iranian patients with ankylosing spondylitis
Through investigating genetic variations, it has been demonstrated that single nucleotide polymorphisms (SNPs) in the IL-23 receptor (IL23R) gene have a critical role in the pathophysiology of ankylosing spondyli...
Citation: BMC Rheumatology 2024 8:14 -
Toll-like receptor 9 (TLR9) genetic variants rs187084 and rs352140 confer protection from Behcet’s disease among Iranians
Behcet’s disease (BD) is a multisystem and multifactorial autoimmune disease characterized by relapsing episodes of oral aphthae, genital ulcers, and ocular and skin lesions. Toll-like receptor 9 (TLR9) has pro-i...
Citation: BMC Rheumatology 2024 8:13 -
Barriers and enablers to engagement in exercise and physical activity in non-English speaking South Asian people with chronic musculoskeletal disease
Exercise and physical activity (EPA) are recommended for people with chronic musculoskeletal disease; however, lower levels of engagement with EPA has been consistently reported in people from the South Asian ...
Citation: BMC Rheumatology 2024 8:12 -
Methotrexate treatment strategies for rheumatoid arthritis: a scoping review on doses and administration routes
To describe the evidence of methotrexate (MTX) initiation strategies in patients with rheumatoid arthritis (RA) and, in the case of non-responders, analyse the efficacy and safety of route and dose optimisation.
Citation: BMC Rheumatology 2024 8:11 -
Patients’ experience of a novel interdisciplinary nurse-led self-management intervention (INSELMA)—a qualitative evaluation
Despite continuous improvements in anti-rheumatic pharmacological treatment, people with chronic inflammatory arthritis still report substantial disease impact. Based on the framework for complex interventions...
Citation: BMC Rheumatology 2024 8:10 -
Association between Impella device support and elevated rates of gout flares: a retrospective propensity-matched study
Impella is an advanced ventricular assist device frequently used as a bridge to heart transplantation. The association of Impella with increased rates of gout flares has not been studied. Our primary aim is to...
Citation: BMC Rheumatology 2024 8:9 -
Participation in cardiovascular screening consultations, the who, when and why - A cohort study on patients with rheumatoid arthritis
In accordance with the EULAR recommendations, the Danish Hospital for Rheumatic Diseases have systematically invited patients with rheumatoid arthritis (RA) to cardiovascular (CV) risk assessment since 2011. P...
Citation: BMC Rheumatology 2024 8:8 -
An assessment of cardiovascular disease hospitalizations and disparities by race in patients with rheumatic disease hospitalizations in Alaska, 2015–2018
There is an increased risk of cardiovascular disease in people with many rheumatic diseases. The primary objective of this study was to evaluate cardiovascular disease hospitalizations in Alaska for people wit...
Citation: BMC Rheumatology 2024 8:7 -
Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study
To explore the trajectory of, and factors contributing to, achievement of individual criteria of minimal disease activity (MDA) in patients with active psoriatic arthritis (PsA) treated with guselkumab.
Citation: BMC Rheumatology 2024 8:6 -
Risk of venous thromboembolism in patients with rheumatoid arthritis: a meta-analysis of observational studies
Thrombotic events, such as venous thromboembolism (VTE) are a major health complication linked to rheumatoid arthritis (RA). We performed a meta-analysis to evaluate the risk of VTE, including deep vein thromb...
Citation: BMC Rheumatology 2024 8:5 -
Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study
Interstitial lung disease (ILD) related to rheumatoid arthritis (RA) is among the leading causes of death and an essential prognostic factor. There is only limited evidence for the safety of anti-rheumatic dru...
Citation: BMC Rheumatology 2024 8:4 -
The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective study
Ankylosing spondylitis(AS) is a chronic inflammatory rheumatic disease primarily affecting the spine and sacroiliac joints. While biologic disease-modifying antirheumatic drugs(bDMARDs) and targeted synthetic ...
Citation: BMC Rheumatology 2024 8:3 -
Cross-sectional association between social and demographic factors and disease activity in rheumatoid arthritis
This study aimed to assess the association between social factors, demographic parameters, and disease activity among rheumatoid arthritis (RA) patients.
Citation: BMC Rheumatology 2024 8:2 -
Clinician and patient views on janus kinase inhibitors in the treatment of inflammatory arthritis: a mixed methods study
Janus kinase inhibitors (JAKi) are new targeted synthetic disease-modifying antirheumatic drugs (DMARDs) licenced in the UK to treat rheumatoid and psoriatic arthritides. Unlike currently often prescribed biol...
Citation: BMC Rheumatology 2024 8:1 -
The study of serum muscarinic acetylcholine receptor subtype 3 (m3AChR)-Specific autoantibodies level in rheumatoid arthritis patients with secondary sjogren syndrome
Dry eyes and mouth are symptoms of Sjogren syndrome, which can occur on its own and be referred to as primary Sjogren syndrome or in conjunction with other rheumatic diseases like rheumatoid arthritis and be r...
Citation: BMC Rheumatology 2023 7:45 -
Decoding the mitochondrial connection: development and validation of biomarkers for classifying and treating systemic lupus erythematosus through bioinformatics and machine learning
Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disease characterized by clinical and pathological diversity. Mitochondrial dysfunction has been identified as a critical pathogenetic factor in ...
Citation: BMC Rheumatology 2023 7:44 -
Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity
To investigate whether baseline serum cartilage oligomeric matrix protein (COMP), patient characteristics, traditional cardiovascular disease (CVD) risk factors and disease activity over time predict CVD, in e...
Citation: BMC Rheumatology 2023 7:43 -
Osteonecrosis as a rare musculoskeletal complication in Behcet’s disease- the largest case series with literature review
Behcet disease (BD) as a variable vessel vasculitis is mainly characterized by ocular involvement, genital and oral aphthosis, and erythema nodosum. However, major organ involvements including gastrointestinal...
Citation: BMC Rheumatology 2023 7:42 -
Employment of patients with rheumatoid arthritis - a systematic review and meta-analysis
Patients with rheumatoid arthritis (RA) have difficulties maintaining employment due to the impact of the disease on their work ability. This review aims to investigate the employment rates at different stages...
Citation: BMC Rheumatology 2023 7:41 -
Efficacy and safety of baricitinib in treatment of systemic lupus erythematosus: a systematic review and meta-analysis
SLE is an autoimmune disease marked by broad immunological dysregulation and multi-system inflammation. Baricitinib is one of the novel treatments for SLE. We conducted this meta-analysis to evaluate its safet...
Citation: BMC Rheumatology 2023 7:40 -
Inflammasomes in rheumatoid arthritis: a pilot study
The inflammasome plays an important role in rheumatoid arthritis (RA), which has rarely been systematically reported. The aim of this study was to understand whether the levels of inflammasomes were related to...
Citation: BMC Rheumatology 2023 7:39 -
Face validity and reliability test of the Danish version of the compliance questionnaire rheumatology in patients with early rheumatoid arthritis
Supporting adherence to medication is an essential part of the treatment and care of patients with rheumatic and musculoskeletal diseases. The Compliance Questionnaire Rheumatology (CQR) measures adherence in ...
Citation: BMC Rheumatology 2023 7:38 -
Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE)
To determine the safety and efficacy of biological agents used in the treatment of systemic lupus erythematosus (SLE) in adults.
Citation: BMC Rheumatology 2023 7:37 -
The student patient alliance: development and formative evaluation of an initiative to support collaborations between patient and public involvement partners and doctoral students
While the integration of patient and public involvement (PPI) in clinical research is now widespread and recommended as standard practice, meaningful PPI in pre-clinical, discovery science research is more dif...
Citation: BMC Rheumatology 2023 7:36 -
Stakeholder perceptions of preventive approaches to rheumatoid arthritis: qualitative study of healthcare professionals’ perspectives on predictive and preventive strategies
There is increasing research interest in the development of preventive treatment for individuals at risk of rheumatoid arthritis (RA). Previous studies have explored the perceptions of at-risk groups and patie...
Citation: BMC Rheumatology 2023 7:35 -
Pericardial effusions and cardiac tamponade in hospitalized systemic sclerosis patients: analysis of the national inpatient sample
Clinically significant pericardial effusions and cardiac tamponade in systemic sclerosis (SSc) patients is uncommon and the factors that contribute to progression of pericardial involvement in SSc patients hav...
Citation: BMC Rheumatology 2023 7:34 -
Heterogeneity of treatment responses in rheumatoid arthritis using group based trajectory models: secondary analysis of clinical trial data
Traditionally rheumatoid arthritis (RA) trials classify patients as responders and non-responders; they ignore the potential range of treatment responses. Group Based Trajectory Models (GBTMs) provide a more r...
Citation: BMC Rheumatology 2023 7:33 -
Implementation of a hybrid healthcare model in rheumatic musculoskeletal diseases: 6-months results of the multicenter Digireuma study
Rheumatic and musculoskeletal diseases (RMDs) require a tailored follow-up that can be enhanced by the implementation of innovative tools. The Digireuma study aimed to test the feasibility of a hybrid follow-u...
Citation: BMC Rheumatology 2023 7:32 -
Effectiveness and cost-effectiveness of a multimodal, physiotherapist-led, vocational intervention in people with inflammatory arthritis: study protocol of the Physiotherapy WORKs trial
Although reduced work ability is a substantial problem among people with inflammatory arthritis (IA), work ability is an underexposed area in clinical practice. Evidence on vocational interventions in IA is li...
Citation: BMC Rheumatology 2023 7:31 -
Cardiac sarcoma presenting as paraneoplastic arthritis and clubbing: a case report and literature review
Cardiac tumours are rare, and clinical manifestations depend on the anatomical location. Symptoms can be the result of cardiac outflow anomalies, constitutional features such as fever, loss of weight, and/or p...
Citation: BMC Rheumatology 2023 7:30 -
Correlation of serum subfatin, cthrc1, ctrp3, ctrp6 levels with disease indices in patients with axial spondyloarthritis
The study aimed to investigate novel biomarkers from the C1q TNF superfamily and evaluate their role in autoimmune inflammatory rheumatic diseases with the goal of identifying an effective biomarker to measure...
Citation: BMC Rheumatology 2023 7:29 -
Osteoporosis-related fractures in men and women with established and early rheumatoid arthritis: predictors and risk compared with the general population
To study the risk of osteoporosis-related fractures in a community-based sample of men and women with rheumatoid arthritis (RA) overall, as well as early (< 1 year of disease duration, follow-up time maximum 1...
Citation: BMC Rheumatology 2023 7:28 -
Effects of lifestyle physical activity and sedentary behaviour interventions on disease activity and patient- and clinician- important health outcomes in rheumatoid arthritis: a systematic review with meta-analysis
Lifestyle physical activity (PA) is defined as any type of PA undertaken as part of daily life. It can include engagement in activities of daily living (i.e., household chores, gardening, walking to work), inc...
Citation: BMC Rheumatology 2023 7:27 -
Exploring the emotional impact of axial Spondyloarthritis: a systematic review and thematic synthesis of qualitative studies and a review of social media
The psychological burden in people with inflammatory arthritis is substantial, yet little is known about the disease-related affect experienced by individuals with axial Spondyloarthritis (axial SpA). The aim ...
Citation: BMC Rheumatology 2023 7:26
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.1
5-year Journal Impact Factor: 2.5
Source Normalized Impact per Paper (SNIP): 0.776
SCImago Journal Rank (SJR): 0.805
Speed 2023
Submission to first editorial decision (median days): 15
Submission to acceptance (median days): 247
Usage 2023
Downloads: 398,220
Altmetric mentions: 294
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication